CD4+ T-cell subsets in inflammatory diseases: Beyond the Th1/Th2 paradigm

International Immunology

Volumn 28, Issue 4, 2016, Pages 163-171

  Hirahara, Kiyoshi ^a   Nakayama, Toshinori ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

Author keywords

epigenetics; memory Th2 cells; pathogenic Th2 (Tpath2) cells; T cell plasticity; Th1 Th2 paradigm

Indexed keywords

TRANSCRIPTION FACTOR;

ALLERGIC DISEASE; ASTHMA; CD4+ T LYMPHOCYTE; CELL HETEROGENEITY; CELL PLASTICITY; EPIGENETICS; HUMAN; IMMUNOPATHOGENESIS; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; ANIMAL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 84964669956     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxw006     Document Type: Review

References (137)

1. Mosmann, T. R. and Coffman, R. L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
2. Reiner, S. L. and Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
3. Pulendran, B. and Artis, D. 2012. New paradigms in type 2 immunity. Science 337:431.
4. Szabo, S. J., Sullivan, B. M., Peng, S. L. and Glimcher, L. H. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21:713.
5. Christen, U. and von Herrath, M. G. 2004. Manipulating the type 1 vs type 2 balance in type 1 diabetes. Immunol. Res. 30:309.
6. Sospedra, M. and Martin, R. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23:683.
7. McDonald, A. H. and Swanborg, R. H. 1988. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J. Immunol. 140:1132.
8. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.
9. Cua, D. J., Sherlock, J., Chen, Y. et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744.
10. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J., and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
11. Attur, M. G., Patel, R. N., Abramson, S. B. and Amin, A. R. 1997. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum. 40:1050.
12. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity 24:179.
13. Bettelli, E., Carrier, Y., Gao, W. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
14. Ivanov, I. I., McKenzie, B. S., Zhou, L. et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121.
15. Yoshida, H., Hamano, S., Senaldi, G. et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569.
16. Villarino, A., Hibbert, L., Lieberman, L. et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.
17. Hirahara, K., Ghoreschi, K., Yang, X. P. et al. 2012. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36:1017.
18. Hirahara, K., Onodera, A., Villarino, A. V. et al. 2015. Asymmetric action of STAT transcription factors drives transcriptional outputs and cytokine specificity. Immunity 42:877.
19. Batten, M., Li, J., Yi, S. et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929.
20. Belge, K., Bruck, J. and Ghoreschi, K. 2014. Advances in treating psoriasis. F1000prime Rep. 6:4.
21. Perera, G. K., Di Meglio, P. and Nestle, F. O. 2012. Psoriasis. Annu. Rev. Pathol. 7:385.
22. Yawalkar, N., Karlen, S., Hunger, R., Brand, C. U. and Braathen, L. R. 1998. Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 111:1053.
23. Ghoreschi, K., Thomas, P., Breit, S. et al. 2003. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9:40.
24. Langley, R. G., Elewski, B. E., Lebwohl, M. et al. 2014. Secukinumab in plaque psoriasis--results of two phase 3 trials. N. Engl. J. Med. 371:326.
25. Griffiths, C. E., Reich, K., Lebwohl, M. et al. 2015. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet 386:541.
26. Ye, P., Rodriguez, F. H., Kanaly, S. et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519.
27. Stockinger, B., Veldhoen, M. and Martin, B. 2007. Th17 T cells: linking innate and adaptive immunity. Semin. Immunol. 19:353.
28. Wills-Karp, M. 2004. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 202:175.
29. Cohn, L., Elias, J. A. and Chupp, G. L. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789.
30. Umetsu, D. T. and DeKruyff, R. H. 2006. The regulation of allergy and asthma. Immunol. Rev. 212:238.
31. Hirahara, K., Yamashita, M., Iwamura, C. et al. 2008. Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness. J. Allergy Clin. Immunol. 122:512.
32. Finkelman, F. D., Hogan, S. P., Hershey, G. K., Rothenberg, M. E. and Wills-Karp, M. 2010. Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 184:1663.
33. Rothenberg, M. E. and Hogan, S. P. 2006. The eosinophil. Annu. Rev. Immunol. 24:147.
34. Wills-Karp, M., Luyimbazi, J., Xu, X. et al. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258.
35. Kerzerho, J., Maazi, H., Speak, A. O. et al. 2013. Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J. Allergy Clin. Immunol. 131:1048.
36. Kaplan, M. H., Hufford, M. M. and Olson, M. R. 2015. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15:295.
37. McKinley, L., Alcorn, J. F., Peterson, A. et al. 2008. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181:4089.
38. Wilson, R. H., Whitehead, G. S., Nakano, H., Free, M. E., Kolls, J. K. and Cook, D. N. 2009. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180:720.
39. Alcorn, J. F., Crowe, C. R. and Kolls, J. K. 2010. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72:495.
40. Kudo, M., Melton, A. C., Chen, C. et al. 2012. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 18:547.
41. Watanabe, Y., Onodera, A., Kanai, U. et al. 2014. Trithorax complex component Menin controls differentiation and maintenance of T helper 17 cells. Proc. Natl Acad. Sci. USA 111:12829.
42. Molet, S., Hamid, Q., Davoine, F. et al. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430.
43. Gibson, P. G., Simpson, J. L. and Saltos, N. 2001. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119:1329.
44. Laan, M., Palmberg, L., Larsson, K. and Lindén, A. 2002. Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur. Respir. J. 19:534.
45. Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L. P. and Hamid, Q. 2003. Airway remodeling- associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111:1293.
46. Choy, D. F., Hart, K. M., Borthwick, L. A. et al. 2015. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci. Transl. Med. 7:301ra129.
47. Korn, T., Bettelli, E., Gao, W. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484.
48. Coquet, J. M., Schuijs, M. J., Smyth, M. J. et al. 2015. Interleukin- 21-producing CD4(+) T cells promote type 2 immunity to house dust mites. Immunity 43:318.
49. Sonnenberg, G. F., Fouser, L. A. and Artis, D. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12:383.
50. Zhao, Y., Yang, J., Gao, Y. D. and Guo, W. 2010. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 151:297.
51. Czarnowicki, T., Gonzalez, J., Shemer, A. et al. 2015. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J. Allergy Clin. Immunol. 136:104.
52. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10:857.
53. Ahlfors, H., Morrison, P. J., Duarte, J. H. et al. 2014. IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J. Immunol. 193:4602.
54. Haldar, P., Pavord, I. D., Shaw, D. E. et al. 2008. Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 178:218.
55. Moore, W. C., Meyers, D. A., Wenzel, S. E. et al. 2010. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181:315.
56. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621.
57. Locci, M., Havenar-Daughton, C., Landais, E. et al. 2013. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39:758.
58. Yamamoto, T., Lynch, R. M., Gautam, R. et al. 2015. Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection. Sci. Transl. Med. 7:298ra120.
59. Busse, W. W., Morgan, W. J., Gergen, P. J. et al. 2011. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 364:1005.
60. Crispin, J. C., Oukka, M., Bayliss, G. et al. 2008. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181:8761.
61. Doreau, A., Belot, A., Bastid, J. et al. 2009. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10:778.
62. Jacquemin, C., Schmitt, N., Contin-Bordes, C. et al. 2015. OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity 42:1159.
63. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
64. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. 2008. Regulatory T cells and immune tolerance. Cell 133:775.
65. Josefowicz, S. Z., Lu, L. F. and Rudensky, A. Y. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531.
66. Ohkura, N., Kitagawa, Y. and Sakaguchi, S. 2013. Development and maintenance of regulatory T cells. Immunity 38:414.
67. Ramsdell, F. and Ziegler, S. F. 2014. FOXP3 and scurfy: how it all began. Nat. Rev. Immunol. 14:343.
68. Abbas, A. K., Benoist, C., Bluestone, J. A. et al. 2013. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14:307.
69. Yadav, M., Louvet, C., Davini, D. et al. 2012. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209:1713.
70. Weiss, J. M., Bilate, A. M., Gobert, M. et al. 2012. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209:1723.
71. Hansen, W., Hutzler, M., Abel, S. et al. 2012. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth. J. Exp. Med. 209:2001.
72. Wing, K., Onishi, Y., Prieto-Martin, P. et al. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271.
73. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27:485.
74. Akdis, M., Palomares, O., van de Veen, W., van Splunter, M. and Akdis, C. A. 2012. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J. Allergy Clin. Immunol. 129:1438.
75. O'Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A. and Kanno, Y. 2011. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 11:239.
76. Szabo, S. J., Sullivan, B. M., Stemmann, C. et al. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338.
77. Zheng, W. and Flavell, R. A. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
78. Chang, H. C., Sehra, S., Goswami, R. et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11:527.
79. Johnston, R. J., Poholek, A. C., DiToro, D. et al. 2009. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325:1006.
80. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
81. Djuretic, I. M., Levanon, D., Negreanu, V., Groner, Y., Rao, A. and Ansel, K. M. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8:145.
82. O'Shea, J. J. and Paul, W. E. 2010. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098.
83. Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K. and O'Shea, J. J. 2012. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30:707.
84. Bonelli, M., Shih, H. Y., Hirahara, K. et al. 2014. Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes. Curr. Topics Microbiol. Immunol. 381:279.
85. Hegazy, A. N., Peine, M., Helmstetter, C. et al. 2010. Interferons direct Th2 Cell reprogramming to generate a stable GATA-3+Tbet+ cell subset with combined Th2 and Th1 cell functions. Immunity 32:116.
86. Ghoreschi, K., Laurence, A., Yang, X. P. et al. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467:967.
87. Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B. and Campbell, D. J. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595.
88. Oestreich, K. J., Huang, A. C. and Weinmann, A. S. 2011. The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J. Exp. Med. 208:1001.
89. Wohlfert, E. A., Grainger, J. R., Bouladoux, N. et al. 2011. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121:4503.
90. Chung, Y., Tanaka, S., Chu, F. et al. 2011. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17:983.
91. Chaudhry, A., Rudra, D., Treuting, P. et al. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986.
92. Schiering, C., Krausgruber, T., Chomka, A. et al. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513:564.
93. Palmer, G. and Gabay, C. 2011. Interleukin-33 biology with potential insights into human diseases. Nat. Rev. Rheumatol. 7:321.
94. Arpaia, N., Green, J. A., Moltedo, B. et al. 2015. A distinct function of regulatory T cells in tissue protection. Cell 162:1078.
95. Zaiss, D. M., Gause, W. C., Osborne, L. C. and Artis, D. 2015. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 42:216.
96. Ohnmacht, C., Park, J. H., Cording, S. et al. 2015. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORgammat(+) T cells. Science 349:989.
97. Sefik, E., Geva-Zatorsky, N., Oh, S. et al. 2015. Mucosal immunology. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349:993.
98. Mahata, B., Zhang, X., Kolodziejczyk, A. A. et al. 2014. Singlecell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis. Cell Rep. 7:1130.
99. Arsenio, J., Kakaradov, B., Metz, P. J., Kim, S. H., Yeo, G. W. and Chang, J. T. 2014. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat. Immunol. 15:365.
100. Endo, Y., Iwamura, C., Kuwahara, M. et al. 2011. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35:733.
101. Endo, Y., Hirahara, K., Iinuma, T. et al. 2015. The interleukin- 33-p38 kinase axis confers memory T helper 2 cell pathogenicity in the airway. Immunity 42:294.
102. Islam, S. A., Chang, D. S., Colvin, R. A. et al. 2011. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat. Immunol. 12:167.
103. Mitson-Salazar, A., Yin, Y., Wansley, D. L. et al. 2015. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T2 cell subpopulation with enhanced function. J. Allergy Clin. Immunol.
104. Upadhyaya, B., Yin, Y., Hill, B. J., Douek, D. C. and Prussin, C. 2011. Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells. J. Immunol. 187:3111.
105. Wambre, E., DeLong, J. H., James, E. A., LaFond, R. E., Robinson, D. and Kwok, W. W. 2012. Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J. Allergy Clin. Immunol. 129:544.
106. Nguyen, L. P., Pan, J., Dinh, T. T. et al. 2015. Role and speciesspecific expression of colon T cell homing receptor GPR15 in colitis. Nat. Immunol. 16:207.
107. Iinuma, T., Okamoto, Y., Yamamoto, H. et al. 2015. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis. Ann. Allergy Asthma Immunol. 114:289.
108. Islam, S. A. and Luster, A. D. 2012. T cell homing to epithelial barriers in allergic disease. Nat. Med. 18:705.
109. Joost, P. and Methner, A. 2002. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 3:RESEARCH0063.
110. Goldberg, A. D., Allis, C. D. and Bernstein, E. 2007. Epigenetics: a landscape takes shape. Cell 128:635.
111. Wei, G., Wei, L., Zhu, J. et al. 2009. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30:155.
112. Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B. and Cavalli, G. 2007. Genome regulation by polycomb and trithorax proteins. Cell 128:735.
113. Nakayama, T. and Yamashita, M. 2008. Initiation and maintenance of Th2 cell identity. Curr. Opin. Immunol. 20:265.
114. Nakayama, T. and Yamashita, M. 2009. Critical role of the Polycomb and Trithorax complexes in the maintenance of CD4 T cell memory. Semin. Immunol. 21:78.
115. Onodera, A. and Nakayama, T. 2015. Epigenetics of T cells regulated by Polycomb/Trithorax molecules. Trends Mol. Med. 21:330.
116. Onodera, A., Tumes, D. J., Watanabe, Y. et al. 2015. Spatial interplay between Polycomb and Trithorax complexes controls transcriptional activity in T lymphocytes. Mol. Cell. Biol. 35:3841.
117. Kimura, M., Koseki, Y., Yamashita, M. et al. 2001. Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene. Immunity 15:275.
118. Yamashita, M., Kuwahara, M., Suzuki, A. et al. 2008. Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene. J. Exp. Med. 205:1109.
119. Suzuki, A., Iwamura, C., Shinoda, K. et al. 2010. Polycomb group gene product Ring1B regulates Th2-driven airway inflammation through the inhibition of Bim-mediated apoptosis of effector Th2 cells in the lung. J. Immunol. 184:4510.
120. Tumes, D. J., Onodera, A., Suzuki, A. et al. 2013. The polycomb protein Ezh2 regulates differentiation and plasticity of CD4(+) T helper type 1 and type 2 cells. Immunity 39:819.
121. Yamashita, M., Hirahara, K., Shinnakasu, R. et al. 2006. Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity 24:611.
122. Obata, Y., Furusawa, Y., Endo, T. A. et al. 2014. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat. Immunol. 15:571.
123. Bulger, M. and Groudine, M. 2011. Functional and mechanistic diversity of distal transcription enhancers. Cell 144:327.
124. Yamashita, M., Ukai-Tadenuma, M., Kimura, M. et al. 2002. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J. Biol. Chem. 277:42399.
125. Ansel, K. M., Djuretic, I., Tanasa, B. and Rao, A. 2006. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24:607.
126. Heintzman, N. D., Hon, G. C., Hawkins, R. D. et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108.
127. Zhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J. and Rothenberg, E. V. 2012. Dynamic transformations of genomewide epigenetic marking and transcriptional control establish T cell identity. Cell 149:467.
128. Hawkins, R. D., Larjo, A., Tripathi, S. K. et al. 2013. Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. Immunity 38:1271.
129. Gerasimova, A., Chavez, L., Li, B. et al. 2013. Predicting cell types and genetic variations contributing to disease by combining GWAS and epigenetic data. PLoS One 8:e54359.
130. Seumois, G., Chavez, L., Gerasimova, A. et al. 2014. Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility. Nat. Immunol. 15:777.
131. Farh, K. K., Marson, A., Zhu, J. et al. 2015. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518:337.
132. Hnisz, D., Abraham, B. J., Lee, T. I. et al. 2013. Superenhancers in the control of cell identity and disease. Cell 155:934.
133. Vahedi, G., Kanno, Y., Furumoto, Y. et al. 2015. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 520:558.
134. Endo, Y., Hirahara, K., Yagi, R., Tumes, D. J. and Nakayama, T. 2014. Pathogenic memory type Th2 cells in allergic inflammation. Trends Immunol. 35:69.
135. Antonelli, A., Ferrari, S. M., Corrado, A., Ferrannini, E. and Fallahi, P. 2014. CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev. 25:57.
136. Lee, Y., Awasthi, A., Yosef, N. et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13:991.
137. Wang, C., Yosef, N., Gaublomme, J. et al. 2015. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163:1413.